Mithu Maheswaranathan, MD

Sorry to hear the lack of support. Especially as it is a rare condition, I understand.

Can check the American Behçet's Disease Association (ABDA) out online and whether any virtual support groups, and maybe CreakyJoints has some information too.

Thank you for sharing! One of my goals is to help the general medical audience better recognize/ identify rheumatic conditions— including #Behcets!

🆕 Visual Abstract w/ Healio Rheumatology 🟢

#Telitacicept in Systemic Lupus
• telitacicept: TACI-Fc fusion protein which targets BLyS/APRIL
• telitacicept: ⇡ response rate vs PBO

📖: van Vollenhoven et al, NEJM
📎: tinyurl.com/telitacicepthealio

#Lupus #MedSky #RheumSky
@gohealio.bsky.social

🆕 Approach to Rheum Labs! 🧪

With the current #rheumatology workforce shortage, better education is needed to increase yield of new patient referrals from referring clinicians:
1️⃣ Joint Pain: when should one refer to #Rheum?
2️⃣ ANA: when should an #ANA be checked?

#MedSky #RheumSky #PositiveANA

I think this one looks clearer… the text is darker on this one!

CC for interest
@kristenyoung.bsky.social
@rheumcat.bsky.social
@lupusdnadoc.bsky.social
@lupuschat.bsky.social
@ladaorg.bsky.social
@lupusresearch.bsky.social

🆕 2025 ACR Guideline for Treatment of Systemic #Lupus Erythematosus 🦋

Just Released: Nov 3 #ACR25 🔥
🔸Review organ-specific treatment recommendations
🔸Steroid & HCQ Use Guidance
🔸Management of Comorbidities

➠ Read the Full Guideline here: acr.tw/47mkegj

#RheumSky #SLE #Rheumatology

That’s a wrap on #ACR25. Great to connect with the #rheumsky #meded community IRL! @davidleverenz.bsky.social @mithurheum.bsky.social @pedsrheum2connect.bsky.social @washumedrheum.bsky.social

🆕 Clinical Year in Review at #ACR25
By Dr. Bryant England @unmc.bsky.social

🔶 Review the most impactful studies in #Rheumatology from the past year!
❓ Any studies you would add to the list?

#RheumSky #MedSky #YearInReview

🆕 Secrets & Pearls of #Rheumatology at #ACR25 | Part 1 by Dr. Janet Pope

🖐️ Cutaneous Pathology SLE/DM
🧴 Tips for SLE 
💪 Cancer Screening in Myositis
🩸 Laboratory Testing
🥶 Raynaud's / Scleroderma
👀 Sjogrens Disease

#RheumSky #MedSky #Lupus #Myositis #Scleroderma #Sjogrens

@rheumcat.bsky.social
@kristenyoung.bsky.social
@lupuschat.bsky.social
@lupusdnadoc.bsky.social
@lupusencyclopedia.bsky.social
@lupusresearch.bsky.social

🆕 ACR 2025 Guidelines for Treatment of Systemic Lupus Erythematosus 🦋

#ACR25 #Lupus #RheumSky

🏷️ for Interest
@rheumnow.bsky.social
@jeffsparks.bsky.social
@pulmpeeps.bsky.social
@icuonepager.bsky.social
@drpujamehta1.bsky.social
@pulmtoilet.bsky.social
@pulmcrit.bsky.social
@thanhneville.medsky.social
@critconcepts.bsky.social
@gretchemaben.bsky.social
@laxswamy.bsky.social

🆕 Collaboration with RheumNow 🔵
*3-Part Series on Interstitial Lung Disease*

Part 3️⃣: Treatment of #ILD
💊 Medication Options for Rx of ILD
🫁 How to Treat Different ILD Subtypes
🚶🏻‍♀️Holistic Approach to Management ❌🚬

#RheumSky #PulmSky #IPF #Rheum #InterstitialLungDisease

Thank you! 😊

🏷️ for Interest
@jeffsparks.bsky.social
@pulmpeeps.bsky.social
@icuonepager.bsky.social
@nickmark.bsky.social
@drpujamehta1.bsky.social
@rheumcat.bsky.social
@didemsayginmd.bsky.social
@kristenyoung.bsky.social
@pulmtoilet.bsky.social
@pulmcrit.bsky.social

🆕 Collaboration with RheumNow 🔵
3-Part Series on Interstitial Lung Disease

Part 2: Diagnosis & Subtypes of #ILD
👩🏻‍⚕️ What to look for on Physical Exam
🧪 Serologic Testing & Diagnostic Workup
🫁 Differentiating ILD Subtypes on Imaging

#RheumSky #PulmSky #MedSky #InterstitialLungDisease

Infographic showing different organ systems affected by Behcets: oral/genital ulcers, skin, vascular, GI, neurologic, ocular and more.

🆕 Behçet's Disease: Let’s explore this multi-system #vasculitis 💫

👄 Oral and Genital Ulcers
🩸 DVT, Arterial Aneurysm
👁️ Uveitis
🧠 Neurologic Involvement
🖐️ Cutaneous Disease / Pathergy

#RheumSky #Behcets #Rheumatology

So often for FUO consults with ID and Heme/Onc 😂

🆕 2024 ACR Guidelines for Screening, Treatment and Management of Lupus Nephritis 🫘
• Just Released: May 7, 2025 🔥

🔸 New Recommendations for Triple Therapy for Class III/IV + V Lupus Nephritis 🦋
🔸 Reduced ⇣ Dose of PO Steroids after IV Pulse! 💊

#LupusNephritis #RheumSky #NephSky #Lupus

Oh sounds interesting! Look forward to reading that.

🆕 PJP Prophylaxis in #Rheumatology 🫁

🔹Discuss risk factors for PJP infection
🔹Risk Stratify: CD4 count <200 or ALC <500 = ⇡Risk
🔹Review Treatment options and when to stop PPx?

#MedSky #RheumSky #PulmSky #PJP

💫 Check out the new Rheum Madness x Rheum One Pagers bracket infographic! 🎉🏀📟

📖 Read most pivotal, innovative studies in #rheum in past 2 yrs
🎙️ Listen to the Rheum Madness podcasts
🏀 Submit Brackets before April 1

@rheummadness.bsky.social
@davidleverenz.bsky.social
@larneson.bsky.social

@lupuschat.bsky.social @lupusdnadoc.bsky.social @ashira-md.bsky.social @alhkim.bsky.social @rheumcat.bsky.social @kristenyoung.bsky.social @creakyjoints.bsky.social @lupusresearch.bsky.social

🆕 #Obinutuzumab (Obi) in Lupus Nephritis: the REGENCY Trial

Phase 3 RCT: Obi vs PBO
🫘 Pts w/ SLE nephritis Class III/IV ± 5
🎲 Randomized 1:1 to OBI v PBO (+MMF/steroids)
📊 Obi: ⇡rate of renal response and improved renal outcomes

#LupusNephritis #RheumSky #NephSky #MedSky #Lupus

Yes good Q whether earlier targeting in the B-cell pathway with inebilizumab will make a significant difference with broader B cell depletion!

Wonder if anyone else on #RheumSky has thoughts!

🆕 Visual Abstract with Healio Rheumatology 🟢

🔥 New Therapy for IgG4-Related Disease: INEBILIZUMAB

💉 RCT of inebilizumab (anti-CD19) vs placebo
👥 Adult pts with IgG4-RD involving ≥ 2 organs
📊 Results:⇣flare rate,⇡remission

#IgG4RD #RareDiseases #Rheumatology #Inebilizumab

Love this #HealthLiteracy 🙌🏽

Happy holidays from the Duke Rheum crew ❄️ ⛄️ 🎄 @mithurheum.bsky.social

Had so much fun! Thanks for hosting us #DukeRheum #Rheumatology ❄️🎄🎁